Patients with node-positive gastric cancer undergoing curative total gastrectomy were intraoperatively randomized to D1 + ( group 1 , 36 patients ) or standard D2 lymphadenectomy ( group 2 , 37 patients ) , the latter including splenectomy and nodal group 12a .